{
  "id": 9940571,
  "title": "New Graft-versus-Host Disease treatments: What’s in the biotech pipeline in 2026?",
  "url": "https://urgent.news/2026/09/25/new-graft-versus-host-disease-treatments-whats-in-the-biotech",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T13:00:00.000Z",
  "source": {
    "name": "Labiotech",
    "slug": "labiotech",
    "url": "https://www.labiotech.eu/in-depth/new-gvhd-treatments/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Over the past decade, a succession of new GvHD treatments targeting different components of the immune response have been approved. The post New Graft-versus-Host Disease treatments: What’s in the biotech pipeline in 2026? appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}